Download MendeleyScaffold-Hopping Approach To Discover Potent, Selective, and Efficacious Inhibitors of NF-kappa B Inducing Kinase.
Blaquiere, N., Castanedo, G.M., Burch, J.D., Berezhkovskiy, L.M., Brightbill, H., Brown, S., Chan, C., Chiang, P.C., Crawford, J.J., Dong, T., Fan, P., Feng, J., Ghilardi, N., Godemann, R., Gogol, E., Grabbe, A., Hole, A.J., Hu, B., Hymowitz, S.G., Alaoui Ismaili, M.H., Le, H., Lee, P., Lee, W., Lin, X., Liu, N., McEwan, P.A., McKenzie, B., Silvestre, H.L., Suto, E., Sujatha-Bhaskar, S., Wu, G., Wu, L.C., Zhang, Y., Zhong, Z., Staben, S.T.(2018) J Med Chem 61: 6801-6813
- PubMed: 29940120
- DOI: https://doi.org/10.1021/acs.jmedchem.8b00678
- Primary Citation of Related Structures:
6G4Y, 6G4Z - PubMed Abstract:
NF-κB-inducing kinase (NIK) is a protein kinase central to the noncanonical NF-κB pathway downstream from multiple TNF receptor family members, including BAFF, which has been associated with B cell survival and maturation, dendritic cell activation, secondary lymphoid organ development, and bone metabolism. We report herein the discovery of lead chemical series of NIK inhibitors that were identified through a scaffold-hopping strategy using structure-based design. Electronic and steric properties of lead compounds were modified to address glutathione conjugation and amide hydrolysis. These highly potent compounds exhibited selective inhibition of LTβR-dependent p52 translocation and transcription of NF-κB2 related genes. Compound 4f is shown to have a favorable pharmacokinetic profile across species and to inhibit BAFF-induced B cell survival in vitro and reduce splenic marginal zone B cells in vivo.
Organizational Affiliation:
Genentech, Inc. , 1 DNA Way , South San Francisco , California 94080 , United States.
